$EXPO
EXPONENT INC Stock $expo

$expo Overview Financials Valuation SEC Filings Company Website

2014 Q3 Form 10-Q Financial Statement

#000114420414048084 Filed on August 08, 2014

Income Statement

Concept	2014 Q3	2014 Q1	2013 Q2
Revenue	$76.57M	$72.80M	$75.51M
YoY Change	1.79%	0.19%	1.37%
Cost Of Revenue	$4.200M	$3.700M	$3.600M
YoY Change	-17.65%	0.0%	-41.94%
Gross Profit	$72.30M	$69.00M	$71.90M
YoY Change	3.14%	0.0%	5.27%
Gross Profit Margin	94.42%	94.78%	95.23%
Selling, General & Admin	$49.80M	$50.20M	$48.10M
YoY Change	2.68%	-3.46%	6.89%
% of Gross Profit	68.88%	72.75%	66.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.300M	$1.300M	$1.300M
YoY Change	0.0%	18.18%	8.33%
% of Gross Profit	1.8%	1.88%	1.81%
Operating Expenses	$60.49M	$56.70M	$57.91M
YoY Change	0.7%	-8.27%	1.38%
Operating Profit	$16.08M	$12.30M	$17.59M
YoY Change	6.09%	13.35%	1.34%
Interest Expense	$0.00	$0.00	$0.00
YoY Change			-100.0%
% of Operating Profit	0.0%	0.0%	0.0%
Other Income/Expense, Net	$2.314M	$2.300M	$678.0K
YoY Change	-1.74%	-13.34%	-700.0%
Pretax Income	$18.40M	$14.70M	$18.27M
YoY Change	5.04%	8.85%	5.93%
Income Tax	$7.134M	$5.900M	$7.423M
% Of Pretax Income	38.78%	40.14%	40.63%
Net Earnings	$11.26M	$8.700M	$10.85M
YoY Change	1.53%	9.08%	5.05%
Net Earnings / Revenue	14.71%	11.95%	14.37%
Basic Earnings Per Share	$0.42		$0.80
Diluted Earnings Per Share	$0.41	$155.9K	$0.77
COMMON SHARES
Basic Shares Outstanding	27.04M shares	13.06M shares	13.64M shares
Diluted Shares Outstanding	27.75M shares		14.01M shares

Balance Sheet

Concept	2014 Q3	2014 Q1	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$144.5M	$156.1M	$123.1M
YoY Change	7.04%	40.63%	12.94%
Cash & Equivalents	$112.9M	$122.9M	$116.6M
Short-Term Investments	$31.60M	$33.20M	$6.400M
Other Short-Term Assets	$24.90M	$18.60M	$18.70M
YoY Change	39.89%	24.0%	31.69%
Inventory
Prepaid Expenses
Receivables	$85.80M	$76.98M	$86.45M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$255.2M	$251.7M	$228.1M
YoY Change	8.6%	21.82%	12.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$28.83M	$28.72M	$28.76M
YoY Change	1.52%	1.49%	7.2%
Goodwill	$8.607M	$8.607M	$8.607M
YoY Change			0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.110M	$551.0K	$580.0K
YoY Change	-97.89%	-98.93%	-3.49%
Total Long-Term Assets	$95.90M	$92.48M	$86.21M
YoY Change	7.15%	4.62%	15.8%
TOTAL ASSETS
Total Short-Term Assets	$255.2M	$251.7M	$228.1M
Total Long-Term Assets	$95.90M	$92.48M	$86.21M
Total Assets	$351.1M	$344.2M	$314.3M
YoY Change	8.2%	16.67%	13.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.00M	$2.798M	$6.000M
YoY Change	96.08%	-60.03%	-33.33%
Accrued Expenses	$47.60M	$5.644M	$44.60M
YoY Change	0.0%	-81.43%	9.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$64.51M	$72.15M	$58.32M
YoY Change	9.53%	68.57%	6.54%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.884M	$1.181M	$1.102M
YoY Change	-94.6%	-96.53%	53.91%
Total Long-Term Liabilities	$1.884M	$1.181M	$1.102M
YoY Change	-94.6%	-96.53%	53.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$64.51M	$72.15M	$58.32M
Total Long-Term Liabilities	$1.884M	$1.181M	$1.102M
Total Liabilities	$105.2M	$109.1M	$91.09M
YoY Change	12.15%	41.88%	13.98%
SHAREHOLDERS EQUITY
Retained Earnings	$233.4M	$226.0M	$210.6M
YoY Change	6.35%		11.52%
Common Stock	$157.6M	$141.3M	$138.7M
YoY Change			15.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$145.6M	$132.4M	$125.4M
YoY Change			12.29%
Treasury Stock Shares	3.339M shares	3.363M shares	3.294M shares
Shareholders Equity	$245.9M	$235.1M	$223.2M
YoY Change
Total Liabilities & Shareholders Equity	$351.1M	$344.2M	$314.3M
YoY Change	8.2%	16.67%	13.63%

Cashflow Statement

Concept	2014 Q3	2014 Q1	2013 Q2
OPERATING ACTIVITIES
Net Income	$11.26M	$8.700M	$10.85M
YoY Change	1.53%	9.08%	5.05%
Depreciation, Depletion And Amortization	$1.300M	$1.300M	$1.300M
YoY Change	0.0%	18.18%	8.33%
Cash From Operating Activities	$16.80M	$28.00M	$21.60M
YoY Change	-3.45%	-638.46%	3.85%
INVESTING ACTIVITIES
Capital Expenditures	$1.061M	-$1.600M	$1.742M
YoY Change	18.95%	-181.67%	168.83%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$20.10M	$3.100M
YoY Change	-100.0%	-279.46%	675.0%
Cash From Investing Activities	-$1.100M	-$21.70M	$1.300M
YoY Change	-85.9%	-333.33%	-750.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.000M	-5.600M	-7.800M
YoY Change	73.08%	-63.16%	-45.83%
NET CHANGE
Cash From Operating Activities	16.80M	28.00M	21.60M
Cash From Investing Activities	-1.100M	-21.70M	1.300M
Cash From Financing Activities	-9.000M	-5.600M	-7.800M
Net Change In Cash	6.700M	700.0K	15.10M
YoY Change	52.27%	-106.31%	143.55%
FREE CASH FLOW
Cash From Operating Activities	$16.80M	$28.00M	$21.60M
Capital Expenditures	$1.061M	-$1.600M	$1.742M
Free Cash Flow	$15.74M	$29.60M	$19.86M
YoY Change	-4.66%	-513.47%	-1.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Goodwill Goodwill	8607000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28721000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	21102000	USD
CY2014Q1	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	33501000	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	85795000	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10450000	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14551000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	8135000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76980000	USD
CY2014Q3	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	34856000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6771000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	72147000	USD
CY2014Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2332000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	468000	USD
CY2014Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8442000	USD
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	56934000	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1110000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1181000	USD
CY2014Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	33447000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122948000	USD
CY2014Q1	us-gaap	Short Term Investments ShortTermInvestments	33171000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	32000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28831000	USD
CY2014Q3	us-gaap	Goodwill Goodwill	8607000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	22498000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	10000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	99000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	551000	USD
CY2014Q1	us-gaap	Assets Assets	344166000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112895000	USD
CY2014Q3	us-gaap	Short Term Investments ShortTermInvestments	31647000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	10330000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	251684000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	255218000	USD
CY2014Q3	us-gaap	Assets Assets	351120000	USD
CY2014Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9985000	USD
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47590000	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6936000	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	64511000	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1884000	USD
CY2014Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	36606000	USD
CY2014Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2200000	USD
CY2014Q3	us-gaap	Liabilities Liabilities	105201000	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	157594000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	109000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	500000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	226040000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	233436000	USD
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	132356000	USD
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	145627000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	235059000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	245919000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	344166000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	351120000	USD
	expo	Vested Restricted Stock Awards Issued To Settle Accrued Bonuses VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses	5807000	USD
CY2014Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.25
CY2013Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2014Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.25
CY2013Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2013Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2014Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3262000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6532000	USD
CY2013Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1998000	USD
CY2014Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3270000	USD
CY2013Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1945000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1965000	USD
CY2014	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7877000	USD
CY2013Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1969000	USD
CY2006Q2	expo	Authorized Common Stock Shares Limit On Use AuthorizedCommonStockSharesLimitOnUse	40000000	shares
CY2006Q2	expo	Authorized Preferred Stock Shares Limit On Use AuthorizedPreferredStockSharesLimitOnUse	2000000	shares
CY2014Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	37099000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	38721000	USD
CY2014Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	108249000	USD
CY2014Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	112816000	USD
CY2014Q1	expo	Deferred Compensation Plan Liabilities Fair Value Disclosure DeferredCompensationPlanLiabilitiesFairValueDisclosure	37926000	USD
CY2014Q3	expo	Deferred Compensation Plan Liabilities Fair Value Disclosure DeferredCompensationPlanLiabilitiesFairValueDisclosure	44169000	USD
CY2014Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	37926000	USD
CY2014Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	44169000	USD
CY2014Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	156103000	USD
CY2014Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	144489000	USD
CY2014Q1	expo	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	25000	USD
CY2014Q3	expo	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	53000	USD
CY2014Q1	expo	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	9000	USD
CY2014Q3	expo	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	0	USD
CY2014Q1	expo	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	156119000	USD
CY2014Q3	expo	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	144542000	USD
CY2014Q3	expo	Available For Sale Securities Short Term Investments Amortized Cost Due In Year One AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne	21321000	USD
CY2014Q3	expo	Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo	10273000	USD
CY2014Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	31594000	USD
CY2014Q3	expo	Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne	21347000	USD
CY2014Q3	expo	Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo	10300000	USD
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2771000	USD
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2927000	USD
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16427000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16427000	shares
CY2014Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3363000	shares
CY2014Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	3339000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13528000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13637000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13520000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13658000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13919000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14007000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13873000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14068000	shares
	expo	Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm	P10Y
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	197988	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	327727	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	14383000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17118000	USD
	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	6050000	USD
CY2013Q2	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	88000	USD
CY2014Q3	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	0	USD
	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	10113000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	9346000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	7902000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	22000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-22000	USD
	expo	Vested Restricted Stock Awards Issued To Settle Accrued Bonuses VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses	6008000	USD
	us-gaap	Revenues Revenues	152536000	USD
CY2013Q2	us-gaap	Revenues Revenues	75505000	USD
CY2014Q3	us-gaap	Revenues Revenues	76574000	USD
	us-gaap	Revenues Revenues	148165000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	30178000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	17593000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	16084000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3687000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3748000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	28444000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1976000	USD
CY2013Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1742000	USD
CY2014Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1061000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3701000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2633000	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1235000	USD
CY2014Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1311000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2384000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2014Q1	expo	Entity Wide Account Receivable Major Customer Percentage EntityWideAccountReceivableMajorCustomerPercentage	0.1	pure
CY2014Q3	expo	Entity Wide Account Receivable Major Customer Percentage EntityWideAccountReceivableMajorCustomerPercentage	0.1	pure
CY2013Q2	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure
CY2014Q3	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	145298000	USD
CY2013Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	71919000	USD
CY2014Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	72331000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	140911000	USD
	us-gaap	Reimbursement Revenue ReimbursementRevenue	7238000	USD
CY2013Q2	us-gaap	Reimbursement Revenue ReimbursementRevenue	3586000	USD
CY2014Q3	us-gaap	Reimbursement Revenue ReimbursementRevenue	4243000	USD
	us-gaap	Reimbursement Revenue ReimbursementRevenue	7254000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	94907000	USD
CY2013Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	44432000	USD
CY2014Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	46049000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	92994000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	12767000	USD
CY2013Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6207000	USD
CY2014Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6450000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	12354000	USD
	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	7238000	USD
CY2013Q2	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	3586000	USD
CY2014Q3	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	4243000	USD
	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	7254000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7446000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7119000	USD
	us-gaap	Operating Expenses OperatingExpenses	122358000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	57912000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	60490000	USD
	us-gaap	Operating Expenses OperatingExpenses	119721000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	84000	USD
CY2013Q2	us-gaap	Investment Income Net InvestmentIncomeNet	36000	USD
CY2014Q3	us-gaap	Investment Income Net InvestmentIncomeNet	40000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	81000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3501000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	642000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2274000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3251000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3585000	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	678000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33763000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	5090000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3807000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6267000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6112000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14383000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	17626000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7134000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12952000	USD
	us-gaap	Net Income Loss NetIncomeLoss	20418000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	10848000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	11264000	USD
	us-gaap	Net Income Loss NetIncomeLoss	18824000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.51
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.38
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18271000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18398000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	31776000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	828000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	473000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7875000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8331000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3896000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1692000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	5090000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.47
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.34
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2013Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2014Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	369000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	317000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-437000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-10000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	8000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20809000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10862000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11589000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18365000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-443000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-137000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-132000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	942000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	3807000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9643000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1558000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3348000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3495000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6504000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-43000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-6027000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-5175000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	165000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1079000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	10730000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16400000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	2186000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	14290000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-857000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	10589000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116644000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1540000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	883000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	6580000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	3967000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-20600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-23015000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	674000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-598000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-10053000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3376000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	113268000	USD
CY2014Q3	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0	USD
CY2014Q3	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2014Q3	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2012Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	35000000	USD
CY2013Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	35000000	USD
CY2014Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	35000000	USD
CY2014Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	51617000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-07-04
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	EXPONENT INC
	dei	Entity Central Index Key EntityCentralIndexKey	0000851520
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-02
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	EXPO
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13087900	shares
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	767000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1067000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD

Files In Submission

Name	View Source	Status
0001144204-14-048084-index-headers.html	Edgar Link	pending
0001144204-14-048084-index.html	Edgar Link	pending
0001144204-14-048084.txt	Edgar Link	pending
0001144204-14-048084-xbrl.zip	Edgar Link	pending
expo-20140704.xml	Edgar Link	completed
expo-20140704.xsd	Edgar Link	pending
expo-20140704_cal.xml	Edgar Link	unprocessable
expo-20140704_def.xml	Edgar Link	unprocessable
expo-20140704_lab.xml	Edgar Link	unprocessable
expo-20140704_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v384825_10q.htm	Edgar Link	pending
v384825_ex31-1.htm	Edgar Link	pending
v384825_ex31-2.htm	Edgar Link	pending
v384825_ex32-1.htm	Edgar Link	pending
v384825_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXPO
EXPONENT INC Stock $expo

2014 Q3 Form 10-Q Financial Statement

#000114420414048084 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXPO EXPONENT INC Stock $expo

2014 Q3 Form 10-Q Financial Statement

#000114420414048084 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXPO
EXPONENT INC Stock $expo